Customers looking for an mRNA therapeutic partner should prioritize operational excellence and choose flexible CDMOs.

Dr. Gregory Bean, Associate Professor of Pathology at Stanford University, will describe the direct detection of mRNA from CRTC1/3::MAML2 translocations, as alternatives to MAML2 FISH, in the ...

Activating stem cells via molecular programming, rather than relying on random cell transplants, significantly enhances the success of regenerative treatments.

Q4 2024 Earnings Call Transcript March 20, 2025 Vaxart, Inc. beats earnings expectations. Reported EPS is $-0.05, ...

An international research team, led by scientists from Tel Aviv University and Sheba Medical Center, has unveiled an innovative method for activating adult stem cells from human bone marrow, enabling ...

This study shows that RNA decay rather than the presence of premature termination codons triggers a TA-like response.

Scientists at the UCLA Health Jonsson Comprehensive Cancer Center and the University of Toronto have revealed how a tiny ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

The FDA cleared the investigational new drug (IND) application for EVM14. EVM14 is an off-the-shelf tumor-associated antigen ...

Why the Section 79 of the IT Act is relevant to the UPSC exam? What is the significance of topics such as Oil imports, ...